About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Division of Hematology/Oncology/Bone Marrow Transplantation
›
top-articles
Division of Hematology/Oncology/Bone Marrow Transplantation
33
(top 2%)
papers
912
(top 2%)
citations
14
(top 2%)
h
-index
29
(top 2%)
g
-index
34
all documents
985
doc citations
295
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
Biology of Blood and Marrow Transplantation
2015
331
2
Improved survival after acute graft-
versus
-host disease diagnosis in the modern era
Haematologica
2017
79
3
Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in the United States (US)
Blood
2019
77
4
Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with Diffuse Large B-Cell Lymphoma (DLBCL): Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR) Cellular Therapy (CT) Registry
Blood
2019
70
5
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
2019
40
6
Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age
Biology of Blood and Marrow Transplantation
2017
38
7
Myeloablative vs reduced intensity T-cell–replete haploidentical transplantation for hematologic malignancy
Blood Advances
2019
38
8
Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT
Journal of Clinical Oncology
2020
36
9
Comparative Analysis of Calcineurin Inhibitor–Based Methotrexate and Mycophenolate Mofetil–Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation
Biology of Blood and Marrow Transplantation
2019
35
10
Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis
Biology of Blood and Marrow Transplantation
2018
34
11
Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World Experience from the Center for International Blood and Marrow Transplant Research (CIBMTR) and Cellular Therapy (CT) Registry
Blood
2019
28
12
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study
Biology of Blood and Marrow Transplantation
2020
21
13
Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation
2019
16
14
Increasing Use of Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients Age 70 Years and Older: A CIBMTR Study of Trends and Outcomes
Biology of Blood and Marrow Transplantation
2016
15
15
The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia
Haematologica
2017
15
16
Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers
Biology of Blood and Marrow Transplantation
2016
14
17
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
2019
14
18
Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT
Bone Marrow Transplantation
2019
14
19
The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time
Biology of Blood and Marrow Transplantation
2019
13
20
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers
Biology of Blood and Marrow Transplantation
2015
12
21
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia
Blood Advances
2019
12
22
Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield
Blood Advances
2020
11
23
Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
2019
10
24
Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors
Biology of Blood and Marrow Transplantation
2020
4
25
Versican Proteolytic Fragments (Matrikines) Regulate the Intratumoral Dendritic Cell Milieu In Vivo: Implications for in Situ Tumor Vaccination
Blood
2019
3
26
T-Replete Haploidentical Cell Transplantation Using Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes
Blood
2018
2
27
Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation
Bone Marrow Transplantation
2018
1
28
Impact of Antibiotics on Gut Microbiota Diversity and the Results of a Prospective Dietary Assessment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation
Blood
2019
1
29
Survival and Late Effects of Children Undergoing Myeloablative Allogeneic HCT at Less Than Three Years of Age: A Report from the Center for International Blood and Marrow Transplant Research
Biology of Blood and Marrow Transplantation
2016
0
30
Impact of Higher-Dose Total Body Irradiation Conditioning on Outcome of an Allogeneic Hematopoietic Cell Transplant (HCT) in the Modern Era
Biology of Blood and Marrow Transplantation
2017
0
31
GATA/Heme Multi-Omics Reveals a Trace Metal-Dependent Erythrocyte Developmental Mechanism
Blood
2018
0
32
A Phase II Study of Decitabine Followed By Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Patients with Myeloid Malignancies
Blood
2018
0
33
Versican (VCAN) Proteolysis Predicts Survival in Multiple Myeloma (MM) after High Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT/AHCT)
Blood
2019
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.